CUBI vs TBBK
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
CUBI presents a stark contradiction between explosive growth and deteriorating fundamental health. While the Piotroski F-Score of 2/9 indicates significant weakness in financial health, the stock is fundamentally undervalued, trading well below its Graham Number ($105.14) and Intrinsic Value ($234.23). Massive YoY earnings growth (579.30%) and a low P/E of 9.37 provide a strong value proposition, but the bearish technical trend (10/100) and poor health score suggest high risk. The overall outlook is neutral until the underlying health metrics stabilize.
TBBK presents a dichotomy between exceptional profitability and deteriorating momentum. The Piotroski F-Score of 4/9 indicates stable but non-improving financial health, while the absence of an Altman Z-Score is typical for the banking sector. While the stock trades at a significant discount to its growth-based intrinsic value ($117.04) and boasts a superior ROE of 30.85%, recent earnings misses and a bearish technical trend suggest a period of consolidation or correction.
Compare Another Pair
Related Comparisons
CUBI vs TBBK: Head-to-Head Comparison
This page compares Customers Bancorp, Inc. (CUBI) and The Bancorp, Inc. (TBBK) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.